Abstract
Purpose: To measure aggregate and particle formation in tumor necrosis factor-alpha (TNF-α) inhibitors etanercept, adalimumab and certolizumab pegol product samples after exposure to freezing temperature conditions similar to storage conditions previously observed in patients’ homes. Methods: TNF-α inhibitors in their original primary and secondary packaging were exposed to 32 freeze-thaw
... read more